Skip to main content

Avadel Pharmaceuticals PLC

AVDLDelisted Feb 12, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001012477

Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Avadel Pharmaceuticals PLC insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Avadel Pharmaceuticals PLC, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Avadel Pharmaceuticals PLC
NameTitleLast reported holdingLast filingFilings, past year
Weiss Asset Management LPOther: Former 10% Owner0IndirectFeb 18, 20261
Weiss Andrew MOther: Former 10% Owner0IndirectFeb 18, 20261
McHugh Thomas SChief Financial Officer0Feb 12, 20261
Thornton Peter J.Director0Feb 12, 20261
McCamish Mark AnthonyDirector0IndirectFeb 12, 20262
Divis Gregory JChief Executive Officer0IndirectFeb 12, 20261
Ende Eric JDirector0Feb 12, 20261
Glass Geoffrey MichaelDirector0IndirectFeb 12, 20261
Amin NaseemDirector0Feb 12, 20261
Palczuk LindaDirector0Feb 12, 20261
Rodriguez SusanChief Operating Officer–Feb 12, 20261
Seurer Jerad G.Gen. Counsel & Corp. Secretary0Feb 12, 20261
Kim Richard JChief Commercial Officer–Mar 4, 20240
Williamson Douglas JChief Medical Officer–Feb 16, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 18, 2026 (view filing)5:18 PM ETFeb 135 daysWeiss Asset Management LP and 1 otherOther: Former 10% OwnerSSale−11.1M$21.00−$233.4M−100.0%0 after
Jan 22, 2025 (view filing)Jan 211 dayPalczuk LindaDirectorPPurchase+5.00K$7.93+$39.6K+7.9%67.9K after
Jan 14, 2025 (view filing)Jan 131 dayThornton Peter J.DirectorPPurchase+10.0K$8.05+$80.5K+10.6%104.1K after
Jan 14, 2025 (view filing)Jan 131 dayEnde Eric JDirectorPPurchase+30.0K$7.84+$235.2K+16.8%208.9K after
Dec 16, 2024 (view filing)Dec 133 daysMcHugh Thomas SChief Financial OfficerPPurchase+2.30K$10.44+$24.0K+2.7%87.8K after
Dec 12, 2024 (view filing)Dec 111 dayMcHugh Thomas SChief Financial OfficerPPurchase+5.00K$10.49+$52.5K+6.2%85.5K after
Dec 10, 2024 (view filing)Dec 6-94 daysDivis Gregory JChief Executive OfficerPPurchase+10.0K$9.97+$99.7KNew position10.0K after2 lots
Dec 10, 2024 (view filing)Dec 10Same dayGlass Geoffrey MichaelDirectorPPurchase+20.3K$9.84+$199.6K+36.5%75.9K after2 lots
Dec 10, 2024 (view filing)Dec 64 daysPalczuk LindaDirectorPPurchase+3.00K$10.19+$30.6K+4.7%66.4K after
Jan 16, 2024 (view filing)Jan 16Same dayMcHugh Thomas SChief Financial OfficerPPurchaseADSs+2.00K$14.50+$29.0K+2.5%80.5K after
Dec 29, 2023 (view filing)Dec 281 dayMcCamish Mark AnthonyDirectorSSaleADSs−75.0K$14.53−$1.09M−52.8%67.0K after10b5-1
Aug 15, 2023 (view filing)Aug 114 daysMcCamish Mark AnthonyDirectorSSaleADSs−29.0K$14.93−$432.6K−16.9%142.0K after
Aug 14, 2023 (view filing)Aug 14Same dayMcHugh Thomas SChief Financial OfficerPPurchaseADSs+2.00K$14.45+$28.9K+2.6%78.5K after
Aug 11, 2023 (view filing)Aug 101 dayGlass Geoffrey MichaelDirectorPPurchaseADSs+14.0K$13.40+$187.6K+31.1%59.0K after
Aug 10, 2023 (view filing)Aug 10Same dayDivis Gregory JChief Executive OfficerPPurchaseADSs+10.0K$13.20+$132.0K+6.7%159.1K after
May 19, 2023 (view filing)May 181 dayEnde Eric JDirectorPPurchaseADSs+13.0K$13.93+$181.1K+8.4%167.9K after
May 10, 2023 (view filing)May 91 dayPalczuk LindaDirectorPPurchaseADSs+2.50K$14.76+$36.9K+5.0%52.4K after
Dec 28, 2022 (view filing)Dec 235 daysPalczuk LindaDirectorPPurchaseADSs+2.00K$7.20+$14.4K+4.2%49.9K after
Nov 30, 2022 (view filing)Nov 291 dayMcHugh Thomas SChief Financial OfficerPPurchaseADSs+5.00K$7.80+$39.0K+7.0%76.5K after
Nov 23, 2022 (view filing)Nov 221 dayEnde Eric JDirectorPPurchaseADSs+20.0K$7.80+$156.0K+14.8%154.9K after
Jun 3, 2022 (view filing)May 313 daysGlass Geoffrey MichaelDirectorPPurchaseADSs+45.0K$2.14+$96.3KNew position45.0K afterAmended
Jun 1, 2022 (view filing)May 31-Jun 11 dayEnde Eric JDirectorPPurchaseADSs+35.0K$2.22+$77.8K+35.0%134.9K after2 lots
May 31, 2022 (view filing)May 274 daysPalczuk LindaDirectorPPurchaseADSs+10.0K$1.60+$16.0K+26.4%47.9K after
May 31, 2022 (view filing)May 274 daysMcHugh Thomas SChief Financial OfficerPPurchaseADSs+50.0K$2.14+$107.0K+232.6%71.5K after
May 31, 2022 (view filing)May 274 daysEnde Eric JDirectorPPurchaseADSs+15.0K$2.45+$36.8K+17.7%99.9K after
May 31, 2022 (view filing)May 274 daysDivis Gregory JChief Executive OfficerPPurchaseADSs+50.0K$2.05+$102.5K+50.5%149.1K after
May 31, 2022 (view filing)May 274 daysThornton Peter J.DirectorPPurchaseADSs+50.0K$1.69+$84.5K+151.3%83.1K after